Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
New and distinct somaclonal variety of rose scented geranium
PP20149 New and distinct somaclonal variety of rose scented geranium

Patent Drawings:
Inventor: Saxena, et al.
Date Issued: July 7, 2009
Application: 09/539,992
Filed: March 30, 2000
Inventors: Saxena; Gauri (Lucknow, IN)
Banerjee; Suchitra (Lucknow, IN)
Rahman; Laiq ur (Lucknow, IN)
Mallavarapu; Gopal Rao (Lucknow, IN)
Sharma; Srikant (Lucknow, IN)
Khanuja; Suman Preet Singh (Lucknow, IN)
Kumar; Sushil (Lucknow, IN)
Assignee: Council of Scientific and Industrial Research (New Delhi, IN)
Primary Examiner: Bell; Kent
Assistant Examiner:
Attorney Or Agent: Abelman, Frayne & Schwab
U.S. Class: PLT/324
Field Of Search: PLT/324
International Class: A01H 5/00
U.S Patent Documents:
Foreign Patent Documents:
Other References: MPEP Chapter 1600--Plant Patents; 11 pages. cited by examiner.

Abstract: A new and distinct somaclone of rose scented geranium Pelargonium graveolens christened `Parimal` characterized by distinct morphology and improved oil yield determining parameters.
Claim: It is claimed:

1. A rose scented Geranium plant named `Parimal`, as herein illustrated and described.
Description: FIELD

The invention provides a new distinct somaclone of rose scented geranium P. graveolens christened as `Parimal` characterized by distinct morphology and improved oil yield determining parameters. The said novel somaclone has been developed fromcallus through in vitro tissue culture technique, without enforced mutagenesis. The plant possesses characteristic leaf morphology, vigorous growth, improved oil content per plant, herb yield and oil yield. The oil produced by this somaclone resemblesthe oil produced by the commercial type of bourbon geranium oil in that has equivalent ratio of citronellol and geraniol.

BACKGROUND OF THE INVENTION

The present invention relates to a new and distinct somaclone of rose scented geranium Pelargonium graveolens a member of the family Geraniaceae, which is a stable somaclone of the Indian cultivar Hemanti. The oil of geranium finds extensive usein perfumery, cosmetics, food and pharmaceutical industries (Narayana, 1986). Geranium was introduced in India in the beginning of this century and since then its cultivation and production of oil remained restricted to the high altitude regions ofOotacamund, Kodaikanal and Yercaud areas in South India (Narayana, 1986). India produces hardly 5 tonnes of geranium oil annually as against its own requirement of approximate 100 tonnes per year (Narayana 1986). The production of oil has declinedgradually over the years and much of the requirement is met by imports. This may be due to narrow genetic base, resulting partially from sexual infertility, vegetative mode of propagation and restricted area of cultivation.

In India, two cultivars of geranium are mainly known; these are the types that produce Algerian or Tunisian quality and the Bourbon or the Reunion quality of geranium oils; these are given the names Pelargonium.times.graveolens cv Hemanti andPelargonium.times.graveolens cv Bipuli, respectively. The cultivar Hemanti was found to be more adaptive than the cultivar Bipuli both in the hilly regions as well as in the unconventional areas of the plains. On the other hand, the cultivar Bipuliscored better than the Hemanti mainly because of its better oil yield and improved organoleptic value of the oil. The perfumery value of geranium oil is mainly determined by the ratio of citronellol and geraniol and almost equal contents of these twomajor terpenoid components is generally considered to be the characteristic of the best quality geranium oil.

In an attempt to extend the area of cultivation of geranium to the Indo-gangetic plains, the better adaptive Hemanti cultivar was introduced in the Lucknow conditions in India. Subsequently, efforts were made through different biotechnologicalmethods to develop clones with high content and desirable composition of the oil. The calliclone `Parimal `evolved through this invention represents improvement over the wild type Hemanti parental cultivar both in terms of quality and quantitydetermining traits of the essential oil. This particular somaclone, being consistently conditions, can offer an improved cultivar for commercial exploitation.

OBJECTS OF THE INVENTION

The main objective of the inventin is to develop useful somaclonal variants of rose scented geranium christened as `Parimal `which are distinct, stable and uniform through successive generations.

Another object is to develop somaclonal variants yielding high quality and quantity of essential oil.

SUMMARY OF THE INVENTIONS

Accordingly the present invention provides a novel variety of rose scented geranium called `Parimal `said plant developed through in vitro tissue culture methods from callus cultures. The invention further provides a useful somaclonal variant`Parimal`of rose scented geranium (Pelargonium graveolens cv. Hemanti) yielding high quality and quantity of essential oil.

DETAILED DESCRIPTIONS

In accordance with the above and other objects, the invention provides a novel somaclone of rose scented geranium called `Parimal`. The said plant has been developed though in vitro tissue cultured on modified Murashige and Skoog's medium (MS),1962.

The invention further provides a useful somaclonal variant `Parimal` of rose scented geranium (Pelargonium graveolens cv. Hemanti) having the following morphological characteristics. Parentage: Pelargonium graveolens cultivar Hemanti. Propagation: Exclusively vegetative propograted through terminal stem cuttings. Time to initiate roots: 15-20 days. Time to produce a rooted young plant through terminal stem cuttings: 30-35 days. Terminal stem cuttings: 30-35 days. Root description:Fibrous, brown in color. Rooting habit: Freely branching, dense. Plant description: General appearance.--Upright, with larger and dense spreading canopy. Growth branching habit.--Vigorous, showing extensive basal tillering. Plant length.--85-95 cm. Growth habit. --Spreading, round canopy. Plant height, to top of foliar plane.--.about.46 cm. Stem.--Green, internodes 8-9 cms long, nodes pinkish Main branches.--Length about 85 cm. diameter about 1.1 cm internode length about 4 cm. texturepubescent, color 138D, color at nodes 75C. Lateral branches.--Length about 70 cm. diameter about 0.7 cm, intermode length about 8 cm. texture pubescent, color 138D. Leaves.--Number per branch 25. Arrangement Alternate. Length .about.6 cm. Width.about.5 cm. Texture pubescent. Shape thick, serrated with round lobes. Apex obtuse. Base cordate. Number of Primary lobes 3. Secondary lobes 12-15. Tip Blunt. Leaf area 20-28 cm.sup.2. Texture (upper surface) pubescent. Texture (lower surface)pubescent. Petiole .about.8 cm (pinkish). Morphological marker Less dentated leaf morphotype (Ldl). Leaf/stem ratio (L/S) 2.1. Herb yield/plant 4.5 kgs. % oil content 0.18 (mean). Oil yield /plant 7.1 gms. (mean). Oil yield (kg/ha) 71.1 (mean). Flower.--No flowering entire lifetime. Seed.--No seed formation. Disease Resistance: Exhibited no specific susceptibility towards the commonly occurring fungus.

This invention further provides the useful somaclonal variant "Parimal" of rose scented geranium (P. graveolens cv. Hemanti) having the following essential oil quality determining characteristics. The average and mean percentage of therespective constituents of the essential oil are provided hereinbelow:

TABLE-US-00001 Essential oil constituents Percentage (%) Linalool 9.1 Cis + Trans rose oxide 0.60 Menthone 0.2 Isomenthone 7.8 Citronellol 27.6 Geraniol 22.6 Citronellyl formate 5.9 Geranyl formate 2.1 Citronellyl acetate 0.2.beta.-caryophyllene 0.2 6,9 guaiadiene 0.6 citronellyl butyrate 1.0 10 Epi-.gamma.-eudesmo 7.3 Citronellyl tiglate 0.8

This invention further provides the said somaclone "Parimal" which exhibited uniqueness with respect to the following RAPD primers:MAP-05, MAP-12, MAP-15 and MAP-16.

The methods and examples for the development of the said novel plant "Parimal" are provided herein below, for illustration of the invention and should not be construed as limitations on the concept of the invention. Modifications that may beapparent to those skilled in the art are deemed to fall within the scope of the present invention.

BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS

The invention is further illustrated with reference to the following drawings wherein:

FIG. 1 Field grown plant of somaclone "Parimal" having large round canopy and profuse branching.

FIG. 2 Field grown plant of wild type parent spreading prostrate canopy and comparatively less branching.

FIG. 3 Leaves of somaclone "Parimal" and wild type showing comparatively less dentation in the leaf of the former than that in the latter.

FIG. (a-d): Variation in the RAPD profiles of wild type parent (C) with that of the selected somaclone "Parimal" (marked with (.fwdarw.)arrow); a:primer MAP-5; b:primer MAP-12; c:primer MAP-15; d: primer MAP-16.

Methods for development of the novel somaclonal variant "Parimal":

Healthy robust shoots, raised by subculturing the organogenic calli on modified MS medium with concentrations of BAP and NAA, were transferred to half strength MS medium with a concentration of indole butyric acid (UBA) for rhizogenesis. Thestem explants were cultured on modified Murashige and Skoog's medium (MS), 1962 containing the following (in mg/L)-NH.sub.4NO.sub.3 (1650), KNO.sub.3 (1900), CaCl.sub.2.2H.sub.2O (400), MgSO.sub.4.7H.sub.2O (370), KH.sub.2PO.sub.4 (170),Na.sub.2EDTA.2H.sub.2O (7.2), FeSO.sub.4.7H.sub.2O (27.8), MnSO.sub.4.4H.sub.2O (22.3), ZnSO.sub.4.7H.sub.2O (8.6), H.sub.3BO.sub.3 (6.2), KI (0.83), Na.sub.2MoO.sub.4.2H.sub.2O (0.25), CuSO.sub.4.5H.sub.2O (0.025), CoCl.sub.2.6H.sub.2O (0.025), Glycine(2.0), Nicotinic acid (0.5), Pyrodoxine HCl (0.5) and Thiamine HCl (0.1) with proportion of naphthelene acetic acid (NAA) and Kinetin (Kn)[2:1]. The best organogenesis (85%) could be achieved by substituting Kinetin with 6-Benzylaminopurine (BAP).

The rooted plants were initially hardened under glass house conditions and were subsequently transferred to the field in the month of October 1996, in replicated trials. Based on the superior performance for vigorous growth resulting fromextensive branching and enlarged canopy size, comparatively better oil yield over that of the control wild type cultivar and distinctively improved oil quality in terms of the major terpenoid constituents, the plant of this invention (Somaclone"Parimal") was selected for further observation and evaluations. During the monsoon seasons of 1996-97, this selected somaclone along with control parent were maintained under glass-house conditions through stem-cuttings which also maintained clonalpurity. The selected clone "Parimal" was grown in field in replicated trials along with its parent Hemanti cultivar for two consecutive winter-summer seasons of 1997-98 and 1998-99, while during the intermediate monsoon season, they were maintainedunder glass-house conditions. The clone "Parimal" maintained its vigorous growth through extensive branching, better oil content and improved oil quality over the three consecutive years. The characteristics of this particular clone (in terms essentialoil quantity and quality determining traits) in relation to that of the control parent and other clones have been represented in Tables-2 and 3. The results clearly demonstrate the outstanding performance of clone "Parimal" over that of the control wildtype parent and other selected clones under Lucknow field conditions, indicating the feasibility of its commercial cultivation in the indo-gangetic plains. It is pertinent to mention ere that the oil profile of somaclone "Parimal" is superior than thatof the wild type parent in having equal content of citronellol and geraniol which is a critical characteristic of best quality commercial geranium oil. The field grown plant of "Parimal" having large round canopy is shown in FIG. 1 and FIG. 2 depictsthe wild type parent. The leaves of "Parimal" are as shown in FIG. 3.

Evidences of uniformity and stability

The somaclone "Parimal" has remained stable and uniform for its morphological characters and showed consistency in performance for various oil yield and quality determining attributes during its field evaluation under Lucknow conditions overthree consecutive years of 1996-97, 1997-98 and 1998-99 are depicted in (Tables 1-3).

Morphological description of the somaclone "Parimal" and its wild type parent

1) Genus -- Pelargonium 2) Species -- graveolens 3) Family -- Geraniaceae 4) Common name -- rose-scented geranium

TABLE-US-00002 TABLE 1 Comparative analysis of oil yield and quality determining traits in the field grown morphologically distinct somaclones, "Parimal" and wild type Pelargonium graveolens CV. Hemanti (control). Soma- % contents of majorterpenoids clone Oil in the essential oil of geranium desig- Morpho- yield/ Cis + trans nation types plant (g) Linalool rose oxide A Highly 4.5 .+-. 0.5 1.1 .+-. 0.2 1.6 .+-. 0.4 B dentated 3.3 .+-. 0.7 1.1 .+-. 0.2 1.3 .+-. 0.3 C leaf 8.6 .+-. 3.7 0.9 .+-. 0.1 1.2 .+-. 0.2 D 4.6 .+-. 1.2 1.0 .+-. 0.3 0.9 .+-. 0.3 Parimal Less 11.3 .+-. 2.8 9.1 .+-. 1.6 0.6 .+-. 0.12 dentated leaf L Less 8.0 .+-. 4.0 8.5 .+-. 2.8 0.6 .+-. 0.1 M dentated 4.5 .+-. 0.8 7.8 .+-. 1.5 0.7 .+-. 0.2 Nleaf 5.1 .+-. 1.6 7.5 .+-. 1.3 0.6 .+-. 0.2 W Highly 3.8 .+-. 0.33 0.7 .+-. 0.1 1.5 .+-. 0.3 (control) dentated Soma- clone % contents of major terpenoids desig- Morpho- in the essential oil of geranium nation types Isomenthone Citronellol GeraniolA Highly 9.6 .+-. 1.8 49.8 .+-. 1.4 2.0 .+-. 0.5 B dentated 9.0 .+-. 2.5 52.6 .+-. 1.9 2.3 .+-. 0.6 C leaf 10.3 .+-. 1.3 51.7 .+-. 1.1 1.8 .+-. 0.4 D 10.6 .+-. 2.1 48.6 .+-. 4.5 2.3 .+-. 1.1 Parimal Less 7.8 .+-. 0.53 27.6 .+-. 2.1 22.6.+-. 3.2 dentated leaf L Less 7.7 .+-. 0.5 28.7 .+-. 4.3 22.3 .+-. 2.8 M dentated 6.9 .+-. 1.5 29.2 .+-. 3.9 20.4 .+-. 2.1 N leaf 7.1 .+-. 1.2 29.1 .+-. 4.4 19.5 .+-. 3.1 W Highly 9.5 .+-. 0.1 53.1 .+-. 0.7 1.6 .+-. 0.14 (control) dentated %contents of major terpenoids Soma- in the essential oil of geranium clone Citronel- desig- Morpho- llyl Geranyl 6,9- 10-epi-.quadrature.- nation types formate formate guaiadiene eudesmol A Highly 13.0 .+-. 0.4 0.5 .+-. 0.3 1.3 .+-. 0.6 2.9 .+-. 0.5 Bdentated 11.7 .+-. 1.3 0.3 .+-. 0.15 1.3 .+-. 0.4 3.0 .+-. 0.7 C leaf 11.1 .+-. 0.9 0.23 .+-. 0.03 1.3 .+-. 0.4 2.9 .+-. 0.5 D 10.2 .+-. 2.7 0.6 .+-. 0.45 1.2 .+-. 0.4 4.4 .+-. 1.4 Parimal Less 5.9 .+-. 0.2 2.1 .+-. 0.4 0.6 .+-. 0.12 7.3.+-. 0.95 dentated leaf L Less 5.6 .+-. 0.7 2.0 .+-. 0.2 0.7 .+-. 0.1 7.4 .+-. 1.1 M dentated 4.8 .+-. 0.7 1.8 .+-. 0.2 0.7 .+-. 0.03 8.6 .+-. 1.8 N leaf 4.7 .+-. 0.8 1.8 .+-. 0.6 0.6 .+-. 0.05 8.2 .+-. 1.6 W Highly 12.1 .+-. 0.6 0.23 .+-. 0.03 2.0 .+-. 0.2 3.2 .+-. 0.2 (control) dentated

TABLE-US-00003 TABLE 2 Morphological characteristics of somaclone "Parimal" and its wild type parent Morphological parameters Parimal Wild type Plant height 85-95 cm 35-45 cm Growth habit spreading, round canopy Spreading prostrate Stem green,internodes Greenish magenta 8-9 cms long, purplish at the nodes, nodes pinkish 5-10 mm in diameter, densely hairy Branches 91-101 10-45 Leaf Number per branch 10-25 25-30 Texture pubescent pubescent Shape thick, serrated with round thick hairy highlylobes serrated Number of primary lobes 3 to 5 secondary lobes 3 15-30 12-15 Tip Blunt Blunt Leaf area 20-28 cm.sup.2 30-36 cm.sup.2 Petiole .about.8 cm (pinkish) .about.5 cm (green)

TABLE-US-00004 TABLE 3 Oil yield and quality determining traits of somaclone "Parimal" and its wild type parent. Somaclone Trait "Parimal" Wild type 1. Morphological marker Less dentated Highly dentated leaf leaf morphotype morphotype (Hdl)(Ldl) 2. Leaf/stem ratio (L/S) 2.1 1.5 3. Herb yield/plant 4.5 kgs. 1.9 kgs 4. % oil content 0.18 0.15 5. Oil yield/plant 7.1 gms. 2.5 gms. 6. Oil yield (kg/ha) 71.1 25.1 7. Oil quality i) Linalool 9.1 0.7 ii) Cis + Trans rose 0.60 1.5 oxideiii) Menthone 0.2 0.3 iv) Isomenthone 7.8 9.5 v) Citronellol 27.6 53.1 vi) Geraniol 22.6 1.6 vii) Citronellyl formate 5.9 12.1 viii) Geranyl formate 2.1 0.2 ix) Citronellyl acetate 0.2 0.9 x) .beta.-caryophyllene 0.2 1.5 xi) 6,9 guaiadiene 0.6 2.0 xii)citronellyl butyrate 1.0 2.2 xiii) 10 Epi-.gamma.-eudesmol 7.3 3.2 xiv) Citronellyl tiglate 0.8 1.6

Type and frequency of variants during multiplication and maintenance of the somaclone

No variants has been recovered during multiplication, maintenance and testing of the somaclone "Parimal" in experimental plots, screened carefully in 1996-97, 1997-98 and 1998-99 winter-summer cropping seasons. The three year's observations onsomaclone "Parimal" were statistically analysed for significance of differences in the morphological oil yield determining attributes and the concentrations of 9 geranium oil quality determining terpenoid constituents. The intraclonal variation in clone"Parimal" was found statistically insignificant over three year's field trial.

Statement of distinction

The somaclones "Parimal" are distinct in having large round canopy, less dentated round leaf morphology, extensive branching and absence of flowering (Table 1). Its oil profile is distinct from the wild type parent cultivar in having higherproportion of geraniol and lower proportion of citronellol, lower content of cis+trans rose oxide and citronellyl formate, 6,9-guadiene, higher content of linalool, geranyl formate and 10-epi-y endesmol (Table-2). Its RAPD profile was different from thewild type parent in certain aspects while had certain features common in both.

Characterization through RAPD markers

Using 13 random primers (MAP 01 to MAP 16) with following sequence description a comparison was made for somaclone "Parimal" and its wild type parent to establish the relatedness between them.

TABLE-US-00005 Primer Base Sequence MAP01 GTGCAATCAG SEQ. ID NO: 1 MAP02 AGGATACGTG SEQ. ID NO: 2 MAP04 AAGATAGCGG SEQ. ID NO: 3 MAP05 GGATCTGAAC SEQ. ID NO: 4 MAP06 TTGTCTCAGG SEQ. ID NO: 5 MAP07 GTCCTACTCG SEQ. ID NO: 6 MAP09 TGCGCGATCGSEQ. ID NO: 7 MAP10 AACGTACGCG SEQ. ID NO: 8 MAP11 GCACGCCGGA SEQ. ID NO: 9 MAP12 CACCCTGCGC SEQ. ID NO: 10 MAP14 GGACTCCACG SEQ. ID NO: 11 MAP15 AAGATAGCGG SEQ. ID NO: 12 MAP16 CTATCGCCGC SEQ. ID NO: 13

This analysis could narrow down with usage of six MAP primers (MAP 04, MAP 05, MAP 10, MAP 14, MAP 15, MAP 16) which in turn were utilized for genotypic pair analysis in order to assess genetic/molecular distances. The following table 4 givesthe similarity index between the two genotypes in paired test.

TABLE-US-00006 TABLE 4 Similarity percentage for amplified bands (paired analysis) of somaclone "Parimal" and wild type parent Primer Genotypic pair (somaclone "Parimal"/wild type) MAP 04 93 MAP 05 80 MAP 10 60 MAP 14 90 MAP 15 83 MAP 16 66

It is evident from similarity indices (paired test) that somaclone "Parimal" and wild type parent are genetically distinguishable (Table 4). Further, the primer MAP 10, MAP 14 showed least similarity while primers MAP 04 and MAP15 showed closerelatedness. The primers MAP05 and MAP16 showed intermediate degree of similarity. These observations on percent similarity confirm the relatedness of somaclone "Parimal" with the wild type parent, at the same time highlight the distinctness of theformer at the genetic level. The complete RAPD profile for PCR amplified DNA segments using 12 primers is available providing evidence of distinctiveness of the clone with respect to the control parent as shown in FIG. 4.

Advantages:

1. "Parimal" is well adaptive to the unconventional area of cultivation i.e. northern Indian plains. 2. "Parimal" represents improvement over its wild type parental cv. "Hemanti" with resepect to the following quantitative traits: (a) Largerand denser canopy; (b) Greater herb yield; (c) Higher leaf:stem ratio; (d) Higher oil content; and (e) Much higher oil yield (both on per plant and per hectare basis). 3. "Parimal" represent improvement over its wild type parental cv. "Hemanti" withrespect to following major essential oil quality determining traits: (a) About equal citronellol:geraniol ratio; (b) Higher rhodinol content; (c) Higher linalool concentration; (d) Lower concentration of 6,9-guaiadiene. 4. The somaclone "Parimal"showed consistency in performance for all the above mentioned oil yield and quality determining attributes during its field evaluation under Lucknow conditions over three consecutive years. 5. "Parimal" showed distinctiveness even at genetic level withrespect to RAPD primers, MAP-05, MAP-12, MAP-15 and MAP-16.

>

Aartificial sequencerandom primers atcag NAARTIFICIAL SEQUENCErandom primer 2 aggatacgtg NAartificial sequencerandom primer 3aagatagcgg NAartificial sequencerandom primer 4 ggatctgaac NAartificial sequencerandom primer 5 ttgtctcagg NAartificial sequencerandom primer 6 gtcctactcg NAartificial sequencerandom primer 7 tgcgcgatcg NAartificialsequencerandom primer 8 aacgtacgcg NAartificial sequencerandom primer 9 gcacgccgga DNAartificial sequencerandom primer ctgcgc DNAartificial sequencerandom primer tccacg DNAartificial sequencerandom primer tagcgg DNAartificial sequencerandom primer cgccgc
* * * * *
 
 
  Recently Added Patents
Mattress systems and methods of making
Storage recovery using a delta log
Communications module, device, and method for implementing a system acquisition function
Current switched circuit for switch mode power amplifiers
Descriptor prefetch mechanism for high latency and out of order DMA device
Liquid discharge apparatus and liquid discharge method
Image forming apparatus having plural air flow paths
  Randomly Featured Patents
Method and apparatus for coating fasteners
Armored stripper rubber
Method of determining toll charges for vehicles using a traffic route
Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
Case packer
Feeding mechanism
Chemiluminescent immunoassay with activator of hydrogen peroxide and a chloramine
Adjustable nozzle assembly for semiconductor wafer backside rinsing
Single step laydown method of making dry fiber with complex fluorine doped profile
Shifting arrangement for a gear wheel change box of a motor vehicle